These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38156858)

  • 1. Update on HPV Vaccination Policies and Practices in 17 Eastern European and Central Asian Countries and Territories.
    Davies P; Aluloski I; Aluloski D; Dizdarevic Maksumic A; Ghayrat Umarzoda S; Gutu V; Ilmammedova M; Janashia A; Kocinaj-Berisha M; Matylevich O; Pidverbetskyy B; Rzayeva G; Sahakyan G; Siljak S; Ten E; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4227-4235. PubMed ID: 38156858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
    Davies P; Aluloski I; Arifdjanova D; Brcanski J; Davidzenka A; Durdyeva A; Gayrat Umarzoda S; Goshliyev K; Jovanovic V; Jugeli L; Kocinaj-Berisha M; Maistruk G; Naumovic T; Pilav A; Rzayeva G; Saribekyan K; Siljak S; Ten E; Valuta D; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E
    Asian Pac J Cancer Prev; 2023 May; 24(5):1781-1788. PubMed ID: 37247301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
    Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
    Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of screening services for cervical and breast cancer - A scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG).
    Vieira-Coimbra M; Nogueira-Martins N; Zadykowicz R; Rodrigues Gaspar H; Calleja-Agius J; Pakiz M; Mukhopadhyay S; Mahmood T
    Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():208-216. PubMed ID: 37679212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level.
    Altobelli E; Rapacchietta L; Profeta VF; Fagnano R
    Cancer Med; 2019 May; 8(5):2524-2534. PubMed ID: 30993902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
    Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
    Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.
    Demarteau N; Breuer T; Standaert B
    Pharmacoeconomics; 2012 Apr; 30(4):337-53. PubMed ID: 22409292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on the implementation of HPV vaccination in Europe.
    Bonanni P; Levi M; Latham NB; Bechini A; Tiscione E; Lai P; Panatto D; Gasparini R; Boccalini S
    Hum Vaccin; 2011; 7 Suppl():128-35. PubMed ID: 21245659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Maver PJ; Poljak M
    Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV Update: Vaccination, Screening, and Associated Disease.
    McNamara M; Batur P; Walsh JME; Johnson KM
    J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.
    McGinnis E; Meyerson BE; Meites E; Saraiya M; Griesse R; Snoek E; Haderxhanaj L; Markowitz LE; Smith W
    Sex Transm Dis; 2017 Oct; 44(10):637-641. PubMed ID: 28876317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
    Jit M; Brisson M; Portnoy A; Hutubessy R
    Lancet Glob Health; 2014 Jul; 2(7):e406-14. PubMed ID: 25103394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of human papillomavirus vaccination in Nordic countries.
    Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
    Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.